I. S. Virk

发表

Noninvasive Home Telemonitoring for Patients With Heart Failure at High Risk for Recurrent Admission and Death

David Tepper, D. Tepper, I. S. Virk, 2005 .

Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated Cardiomyopathy

A. Khasnis, J. Ip, I. S. Virk, 2004 .

Diurnal Blood Pressure Pattern and Risk of Congestive Heart Failure

D. Tepper, I. S. Virk, 2006 .

Temperature dependence of the compressive strength of as-cast cubic zirconium trialuminides

I. S. Virk, R. Varin, 1991 .

Nicardipine and adenosine "flush cocktail" to prevent no-reflow during rotational atherectomy.

I. S. Virk, T. Fischell, S. Haller, 2008, Cardiovascular revascularization medicine : including molecular interventions.

Combination of Isosorbide Dinitrate and Hydralazine in Blacks With Heart Failure

I. S. Virk, R. Ip, Randy J. Ip, 2005 .

Should ? Blockers Be First in Chronic Heart Failure?. Revised ACC/AHA Heart Failure Management Guidelines Reflect Current Clinical Practice

D. Tepper, I. S. Virk, John Ip, 2005 .

Editor's Mailbox

I. S. Virk, Y. Mishriki, 2004 .

Is the Prophylactic Implantable Cardioverter‐Defibrillator Cost‐Effective?

D. Tepper, I. S. Virk, John Ip, 2006 .

Depression May Worsen Heart Failure Outcomes

D. Tepper, I. S. Virk, Rubinder S. Ruby, 2007 .

Reversal of End‐Stage Heart Failure: Mechanical and Pharmacologic Interplay

D. Tepper, I. S. Virk, John Ip, 2007 .

Reversal of End-Stage Heart Failure: Mechanical and Pharmacologic Interplay. Limited Exercise Capacity in Diastolic Dysfunction: Etiologic Perspective

D. Tepper, I. S. Virk, 2007 .

Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea

A. Khasnis, J. Ip, I. S. Virk, 2004 .

T‐Wave Alternans: Is It an Appropriate Test for Primary Prevention Implantable Cardioverter‐Defibrillator Risk Stratification?

D. Tepper, I. S. Virk, John Ip, 2006 .

Rosiglitazone and heart failure: the controversy and clinical implications.

D. Tepper, I. S. Virk, Rubinder S. Ruby, 2007, Congestive heart failure.

Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure: the SURVIVE Randomized Trial

D. Tepper, I. S. Virk, Rubinder S. Ruby, 2007 .

Changing Incidence and Survival for Heart Failure

D. Tepper, I. S. Virk, John Ip, 2006 .

The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. Short-Term Risk of Death After Treatment With Nesiritide for Decompensated Heart Failure

I. S. Virk, John Ip, 2005 .

The Debate Over Anticoagulation in Patients With Heart Failure

D. Tepper, J. Ip, I. S. Virk, 2006 .

Structure and mechanical properties of boron-doped cubic zirconium trialuminides

I. S. Virk, R. Varin, 1992 .

WS11a1 – MECHANICAL BEHAVIOUR OF MODIFIED Al3Ti AND Al3Zr INTERMETALLIC ALLOYS WITH ORDERED FCC STRUCTURE

I. S. Virk, R. Varin, M. Winnicka, 1992 .

Development of structure and porosity in cast Al5CuZr2 and Al66Mn9Zr25 intermetallic compounds

I. S. Virk, R. Varin, 1991 .

Mechanical behavior and microcracking of cubic ternary zirconium trialuminides

I. S. Virk, R. Varin, 1992 .

Structure of as cast L12 compounds in Al3Zr — Base alloys containing Cu and Mn

I. S. Virk, R. Varin, 1991 .

DEPENDENCE OF VICKERS MICROHARDNESS ON LOAD IN THE L12 TITANIUM AND ZIRCONIUM TERNARY TRIALUMINIDES

I. S. Virk, R. Varin, M. Winnicka, 1990 .